Effect of Delayed-Release Ursodeoxycholic Acid on Insulin Sensitivity, Gastric Emptying and Body Weight in Overweight or Obese Patients With Type 2 Diabetes on Metformin Treatment
Phase of Trial: Phase II
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Ursodeoxycholic acid (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Aug 2017 Status changed from active, no longer recruiting to completed.
- 18 Dec 2015 Planned End Date changed from 1 Oct 2014 to 1 Oct 2016 as reported by ClinicalTrials.gov.